# High-throughput high content quantification of HIV-1 viral infectious output

**Authors:** Teresa LuPone, Alexis Brantly, Oluwatofunmi Oteju, Stephanie M. Matt, Kaitlyn Runner, Emily A. Nickoloff-Bybel, Michael R. Nonnemacher, Peter J. Gaskill

PMC · DOI: 10.1371/journal.pone.0328121 · PLOS One · 2026-03-26

## TL;DR

A new high-content imaging assay helps study HIV-1 infection dynamics by measuring infectivity and p24 secretion efficiently.

## Contribution

A modified GHOST cell assay enables high-throughput quantification of HIV-1 infectivity and p24 secretion.

## Key findings

- The assay allows rapid and consistent evaluation of large sample sets.
- It correlates infectivity with p24 secretion for better understanding of HIV-1 infection kinetics.

## Abstract

Infection with human immunodeficiency virus (HIV-1) remains a global health issue and still drives the development of significant pathology and various comorbidities. Antiretroviral therapy (ART) can effectively suppress viral replication but is often initiated months or years after initial infection, leaving a substantial period in which viral replication progresses unchecked. While ART suppresses HIV-1 replication, it does not prohibit the development of HIV-1-associated comorbidities, highlighting a lack of understanding in the connection between replication and HIV-1-associated pathogeneses. Further, a high percentage of all HIV-1 virions produced are non-infectious, and this proportion is much higher in ART-treated individuals, showing that despite inefficient viral replication, which becomes even less efficient with ART, HIV-1 is still able to drive disease. Thus, it is critical to better define HIV-1 replication dynamics to more effectively target different stages of the viral replication cycle in distinct cell populations. Here, we show a high-content imaging reporter assay that uses modified human osteosarcoma cells expressing HIV-1 receptors (GHOST cells) which fluoresce in response to HIV-1 infection. These cells have been previously used to assess HIV-1 infectivity and tropism, but this modified assay enables rapid evaluation of large numbers of samples with consistency and replicability, while also easily integrating into existing experimental pipelines that analyze p24 secretion in collected supernatants. This also allows for direct correlation between infectivity and p24 secretion, resulting in a deeper interrogation and more robust understanding of HIV-1 infection kinetics.

## Linked entities

- **Proteins:** TMED2 (transmembrane p24 trafficking protein 2)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** gag (Pr55(Gag)) [NCBI Gene 155030], CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, SUCO (SUN domain containing ossification factor) [NCBI Gene 51430] {aka C1orf9, CH1, OPT, SLP1}, CCR3 (C-C motif chemokine receptor 3) [NCBI Gene 1232] {aka C C CKR3, CC-CKR-3, CD193, CKR 3, CKR3, CMKBR3}, TMED2 (transmembrane p24 trafficking protein 2) [NCBI Gene 10959] {aka P24A, RNP24, p24, p24b1, p24beta1}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, TAT (tyrosine aminotransferase) [NCBI Gene 6898], CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** hMDM (MESH:D055501), inflammation (MESH:D007249), osteosarcoma (MESH:D012516), Infection (MESH:D007239), HIV (MESH:D015658), MDM (MESH:D007645), AIDS (MESH:D000163)
- **Chemicals:** Amino acids (MESH:D000596), penicillin (MESH:D010406), DMSO (MESH:D004121), Tween (MESH:D011136), CO2 (MESH:D002245), S (MESH:D013455), Puromycin (MESH:D011691), glycine (MESH:D005998), P (MESH:D010758), H2O (MESH:D014867), FugeneHD (-), polybrene (MESH:D006583), streptomycin (MESH:D013307), Hygromycin (MESH:C026273), Glutamax (MESH:C054122), HEPES (MESH:D006531), EDTA (MESH:D004492), G418 (MESH:C010680), biotin (MESH:D001710)
- **Species:** Human adenovirus 5 (no rank) [taxon 28285], Human immunodeficiency virus (species) [taxon 12721], Coronaviridae (family) [taxon 11118], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A 10X
- **Cell lines:** Hi — Trichoplusia ni (Cabbage looper), Spontaneously immortalized cell line (CVCL_C190), CEM — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0207), JLTRG-R5 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_1E02), Lenti-X — Homo sapiens (Human), Transformed cell line (CVCL_4401), GHOST — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_S489), Ghost Hi5 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_1E17), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), TZM-bL — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B478), CH167 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_V058), CEM SS — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_J318)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13020823/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13020823/full.md

## References

99 references — full list in the complete paper: https://tomesphere.com/paper/PMC13020823/full.md

---
Source: https://tomesphere.com/paper/PMC13020823